| Non-Alcoholic Fatty Liver Disease |
1 |
1 |
| Biliary Disease |
0 |
1 |
| Metabolic Syndrome |
0 |
0.88 |
| Heart Failure (HF) |
0 |
0.76 |
| Heart |
0 |
0.66 |
| Cardiovascular Risk Management |
0 |
0.65 |
| Liver Disease |
0 |
0.63 |
| Liver |
0 |
0.58 |
| Aminotransferase |
0 |
0.44 |
| Fatty Liver |
0 |
0.44 |
| Hepatic Fibrosis |
0 |
0.44 |
| Hypertension |
0 |
0.42 |
| Atrial Fibrillation |
0 |
0.4 |
| Arrhythmia |
0 |
0.38 |
| Hepatocellular Carcinoma |
0 |
0.29 |
| Meta-Analysis |
0 |
0.27 |
| Biomarker |
0 |
0.12 |
| Histology |
0 |
0.08 |
| Renal Failure |
0 |
0.07 |
| Coronary Atherosclerosis |
0 |
0.06 |
| Renal Disease |
0 |
0.06 |
| Chronic Kidney Disease |
0 |
0.05 |
| Lipids Management |
0 |
0.05 |
| Acute Coronary Syndrome |
0 |
0.04 |
| Atherosclerosis |
0 |
0.04 |
| Cancer |
0 |
0.04 |
| Cardiovascular disease |
0 |
0.04 |
| Cirrhosis |
0 |
0.04 |
| Endocrinology |
0 |
0.04 |
| Europe |
0 |
0.04 |
| Grant |
0 |
0.04 |
| Injury |
0 |
0.04 |
| Kidney |
0 |
0.04 |
| Nonalcoholic Steatohepatitis |
0 |
0.04 |
| Primary Care |
0 |
0.04 |
| Stress |
0 |
0.04 |
| Texas |
0 |
0.04 |
| UK Site Content |
0 |
0.04 |
| Obesity |
0 |
0.03 |
| Wound Management |
0 |
0.03 |